The role of organelle stresses in diabetes mellitus and obesity: Implication for treatment

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Chang, Yi Cheng ^a,b,c   Hee, Siow Wey ^b   Hsieh, Meng Lun ^a   Jeng, Yung Ming ^a,b   Chuang, Lee Ming ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; CARNITINE; CHAPERONE; ELAMIPRETIDE; IMATINIB; INSULIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; TAUROURSODEOXYCHOLIC ACID; THIOCTIC ACID; TREHALOSE; UBIDECARENONE; VALPROIC ACID;

AUTOPHAGY; CALORIC RESTRICTION; CELL DIFFERENTIATION; CELL STRESS; CLEARANCE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; FRIEDREICH ATAXIA; GENE FUNCTION; HUMAN; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; KEARNS SAYRE SYNDROME; LIPID LIVER LEVEL; LIPOGENESIS; MELAS SYNDROME; METABOLIC DISORDER; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; UNFOLDED PROTEIN RESPONSE; WEIGHT REDUCTION; WHITE ADIPOCYTE; WOLFRAM SYNDROME; ANIMAL; CELL ORGANELLE; MITOCHONDRION; PATHOLOGY; PHYSIOLOGICAL STRESS;

ANIMALS; AUTOPHAGY; DIABETES MELLITUS, TYPE 2; HUMANS; MITOCHONDRIA; OBESITY; ORGANELLES; STRESS, PHYSIOLOGICAL;

EID: 84947589548     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/972891     Document Type: Review

References (131)

1. A. R. Saltiel, "Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases," The Journal of Clinical Investigation, vol. 106, no. 2, pp. 163-164, 2000.
2. W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin," The New England Journal of Medicine, vol. 346, no. 6, pp. 393-403, 2002.
3. J. Tuomilehto, J. Lindström, J. G. Eriksson et al., "Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance," The New England Journal of Medicine, vol. 344, no. 18, pp. 1343-1350, 2001.
4. R. J. Colman, R. M. Anderson, S. C. Johnson et al., "Caloric restriction delays disease onset and mortality in rhesus monkeys," Science, vol. 325, no. 5937, pp. 201-204, 2009.
5. A. R. Saltiel and C. R. Kahn, "Insulin signalling and the regulation of glucose and lipid metabolism," Nature, vol. 414, no. 6865, pp. 799-806, 2001.
6. K. D. Copps and M. F. White, "Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2," Diabetologia, vol. 55, no. 10, pp. 2565-2582, 2012.
7. D. Ron and P. Walter, "Signal integration in the endoplasmic reticulum unfolded protein response," Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519-529, 2007.
8. N. K. Sharma, S. K. Das, A. K. Mondal et al., "Endoplasmic retic-ulum stress markers are associated with obesity in nondiabetic subjects," Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. 4532-4541, 2008.
9. M. F. Gregor, L. Yang, E. Fabbrini et al., "Endoplasmic reticulum stress is reduced in tissues of obese subjects afer weight loss," Diabetes, vol. 58, no. 3, pp. 693-700, 2009.
10. A. Tsutsumi, H. Motoshima, T. Kondo et al., "Caloric restriction decreases ER stress in liver and adipose tissue in ob/ob mice," Biochemical and Biophysical Research Communications, vol. 404, no. 1, pp. 339-344, 2011.
11. U. Özcan, Q. Cao, E. Yilmaz et al., "Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes," Science, vol. 306, no. 5695, pp. 457-461, 2004.
12. Y. Zhou, J. Lee, C. M. Reno et al., "Regulation of glucose home-ostasis through a XBP-1-FoxO1 interaction," Nature Medicine, vol. 17, no. 3, pp. 356-365, 2011.
13. Y. Deng, Z. V. Wang, C. Tao et al., "The Xbp1s/GalE axis links ER stress to postprandial hepatic metabolism," The Journal of Clinical Investigation, vol. 123, no. 1, pp. 455-468, 2013.
14. D. Scheuner, B. Song, E. McEwen et al., "Translational control is required for the unfolded protein response and in vivo glucose homeostasis," Molecular Cell, vol. 7, no. 6, pp. 1165-1176, 2001.
15. S. Oyadomari, H. P. Harding, Y. Zhang, M. Oyadomari, and D. Ron, "Dephosphorylation of translation initiation factor 2α enhances glucose tolerance and attenuates hepatosteatosis in mice," Cell Metabolism, vol. 7, no. 6, pp. 520-532, 2008.
16. Y. Wang, L. Vera, W. H. Fischer, and M. Montminy, "The CREB coactivator CRTC2 links hepatic ER stress and fasting gluconeogenesis," Nature, vol. 460, no. 7254, pp. 534-537, 2009.
17. H. L. Kammoun, H. Chabanon, I. Hainault et al., "GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice," The Journal of Clinical Investigation, vol. 119, no. 5, pp. 1201-1215, 2009.
18. Y. Nakatani, H. Kaneto, D. Kawamori et al., "Involvement of endoplasmic reticulum stress in insulin resistance and diabetes," The Journal of Biological Chemistry, vol. 280, no. 1, pp. 847-851, 2005.
19. M. Kaneko, Y. Niinuma, and Y. Nomura, "Activation signal of nuclear factor-κB in response to endoplasmic reticulum stress is transduced via IRE1 and tumor necrosis factor receptor-associated factor 2," Biological and Pharmaceutical Bulletin, vol. 26, no. 7, pp. 931-935, 2003.
20. J. Deng, P. D. Lu, Y. Zhang et al., "Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2," Molecular and Cellular Biology, vol. 24, no. 23, pp. 10161-10168, 2004.
21. H. Yamazaki, N. Hiramatsu, K. Hayakawa et al., "Activation of the Akt-NF-κB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response," The Journal of Immunology, vol. 183, no. 2, pp. 1480-1487, 2009.
22. A.-H. Lee, E. F. Scapa, D. E. Cohen, and L. H. Glimcher, "Regulation of hepatic lipogenesis by the transcription factor XBP1," Science, vol. 320, no. 5882, pp. 1492-1496, 2008.
23. E. Bobrovnikova-Marjon, G. Hatzivassiliou, C. Grigoriadou et al., "PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte diferentiation," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16314-16319, 2008.
24. K. Yamamoto, K. Takahara, S. Oyadomari et al., "Induction of liver steatosis and lipid droplet formation in ATF6α-knockout mice burdened with pharmacological endoplasmic reticulum stress," Molecular Biology of the Cell, vol. 21, no. 17, pp. 2975-2986, 2010.
25. D. T. Rutkowski, J. Wu, S.-H. Back et al., "UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators," Developmental Cell, vol. 15, no. 6, pp. 829-840, 2008.
26. T. Iwawaki, R. Akai, K. Kohno, and M. Miura, "A transgenic mouse model for monitoring endoplasmic reticulum stress," Nature Medicine, vol. 10, no. 1, pp. 98-102, 2004.
27. A.-H. Lee, K. Heidtman, G. S. Hotamisligil, and L. H. Glimcher, "Dual and opposing roles of the unfolded protein response regulated by IRE1α and XBP1 in proinsulin processing and insulin secretion," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 21, pp. 8885-8890, 2011.
28. S. H. Back, D. Scheuner, J. Han et al., "Translation attenuation through eIF2α phosphorylation prevents oxidative stress and maintains the diferentiated state in β cells," Cell Metabolism, vol. 10, no. 1, pp. 13-26, 2009.
29. Y. Gao, D. J. Sartori, C. Li et al., "PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis," Molecular and Cellular Biology, vol. 32, no. 24, pp. 5129-5139, 2012.
30. W.Zhang,D.Feng,Y.Li,K.Iida,B.McGrath,andD.R.Cavener, "PERK EIF2AK3 control of pancreatic beta cell diferentiation and proliferation is required for postnatal glucose homeostasis," Cell Metabolism, vol. 4, no. 6, pp. 491-497, 2006.
31. M. Delépine, M. Nicolino, T. Barrett, M. Golamaully, G. M. Lathrop, and C. Julier, "EIF2AK3, encoding translation initiation factor 2-α kinase 3, is mutated in patients with Wolcott-Rallison syndrome," Nature Genetics, vol. 25, no. 4, pp. 406-409, 2000.
32. S. Oyadomari, A. Koizumi, K. Takeda et al., "Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes," Journal of Clinical Investigation, vol. 109, no. 4, pp. 525-532, 2002.
33. K. F. Petersen, S. Dufour, D. Befroy, R. Garcia, and G. I. Shulman, "Impaired mitochondrial activity in the insulin-resistant ofspring of patients with type 2 diabetes," The New England Journal of Medicine, vol. 350, no. 7, pp. 664-671, 2004.
34. K. F. Petersen, D. Befroy, S. Dufour et al., "Mitochondrial dysfunction in the elderly: possible role in insulin resistance," Science, vol. 300, no. 5622, pp. 1140-1142, 2003.
35. D. E. Befroy, K. F. Petersen, S. Dufour et al., "Impaired mitochondrial substrate oxidation in muscle of insulin-resistant ofspring of type 2 diabetic patients," Diabetes, vol. 56, no. 5, pp. 1376-1381, 2007.
36. V. K. Mootha, C. M. Lindgren, K.-F. Eriksson et al., "PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes," Nature Genetics, vol. 34, no. 3, pp. 267-273, 2003.
37. M. E. Patti, A. J. Butte, S. Crunkhorn et al., "Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8466-8471, 2003.
38. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans," The Journal of Clinical Investigation, vol. 119, no. 3, pp. 573-581, 2009.
39. C. Bonnard, A. Durand, S. Peyrol et al., "Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice," Journal of Clinical Investigation, vol. 118, no. 2, pp. 789-800, 2008.
40. S. Furukawa, T. Fujita, M. Shimabukuro et al., "Increased oxida-tive stress in obesity and its impact on metabolic syndrome," The Journal of Clinical Investigation, vol. 114, no. 12, pp. 1752-1761, 2004.
41. H. Ichijo, E. Nishida, K. Irie et al., "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways," Science, vol. 275, no. 5296, pp. 90-94, 1997.
42. K. Imoto, D. Kukidome, T. Nishikawa et al., "Impact of mitochondrial reactive oxygen species and apoptosis signal-regulating kinase 1 on insulin signaling," Diabetes, vol. 55, no. 5, pp. 1197-1204, 2006.
43. K. Asehnoune, D. Strassheim, S. Mitra, J. Y. Kim, and E. Abraham, "Involvement of reactive oxygen species in Tolllike receptor 4-dependent activation of NF-κB," The Journal of Immunology, vol. 172, no. 4, pp. 2522-2529, 2004.
44. M. E. Grifn, M. J. Marcucci, G. W. Cline et al., "Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade," Diabetes, vol. 48, no. 6, pp. 1270-1274, 1999.
45. J. K. Kim, J. J. Fillmore, M. J. Sunshine et al., "PKC-κ knockout mice are protected from fat-induced insulin resistance," Journal of Clinical Investigation, vol. 114, no. 6, pp. 823-827, 2004.
46. S. C. Cheol, D. B. Savage, L. Abu-Elheiga et al., "Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 42, pp. 16480-16485, 2007.
47. S. I. Itani, N. B. Ruderman, F. Schmieder, and G. Boden, "Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha," Diabetes, vol. 51, no. 7, pp. 2005-2011, 2002.
48. W. L. Holland, J. T. Brozinick, L.-P. Wang et al., "Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance," Cell Metabolism, vol. 5, no. 3, pp. 167-179, 2007.
49. J. A. Pospisilik, C. Knauf, N. Joza et al., "Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes," Cell, vol. 131, no. 3, pp. 476-491, 2007.
50. J. Lin, P.-H. Wu, P. T. Tarr et al., "Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice," Cell, vol. 119, no. 1, pp. 121-135, 2004.
51. T. C. Leone, J. J. Lehman, B. N. Finck et al., "PGC-1alpha def-ciency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis," PLoS Biology, vol. 3, no. 4, article e101, 2005.
52. A. Wredenberg, C. Freyer, M. E. Sandström et al., "Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance," Biochemical and Biophysical Research Communications, vol. 350, no. 1, pp. 202-207, 2006.
53. C. Vernochet, A. Mourier, O. Bezy et al., "Adipose-specifc deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance," Cell Metabolism, vol. 16, no. 6, pp. 765-776, 2012.
54. C. M. Kusminski, W. L. Holland, K. Sun et al., "MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity," Nature Medicine, vol. 18, no. 10, pp. 1539-1551, 2012.
55. M. P. Murphy, "How mitochondria produce reactive oxygen species," Biochemical Journal, vol. 417, no. 1, pp. 1-13, 2009.
56. T. J. Schulz, K. Zarse, A. Voigt, N. Urban, M. Birringer, and M. Ristow, "Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress," Cell Metabolism, vol. 6, no. 4, pp. 280-293, 2007.
57. J. Yun and T. Finkel, "Mitohormesis," Cell Metabolism, vol. 19, no. 5, pp. 757-766, 2014.
58. P. Maechler and C. B. Wollheim, "Mitochondrial function in normal and diabetic β-cells," Nature, vol. 414, no. 6865, pp. 807-812, 2001.
59. S. DiMauro and E. A. Schon, "Mitochondrial respiratory-chain diseases," The New England Journal of Medicine, vol. 348, no. 26, pp. 2656-2668, 2003.
60. T. Kadowaki, H. Kadowaki, Y. Mori et al., "A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA," The New England Journal of Medicine, vol. 330, no. 14, pp. 962-968, 1994.
61. J. P. Silva, M. Köhler, C. Graf et al., "Impaired insulin secretion and beta-cell loss in tissue-specifc knockout mice with mito-chondrial diabetes," Nature Genetics, vol. 26, no. 3, pp. 336-340, 2000.
62. M. Ristow, H. Mulder, D. Pomplun et al., "Frataxin defciency in pancreatic islets causes diabetes due to loss of β cell mass," Journal of Clinical Investigation, vol. 112, no. 4, pp. 527-534, 2003.
63. R. L. Hewer, "Study of fatal cases of Friedreich,s ataxia," British Medical Journal, vol. 3, no. 619, pp. 649-652, 1968.
64. N. Mizushima and M. Komatsu, "Autophagy: renovation of cells and tissues," Cell, vol. 147, no. 4, pp. 728-741, 2011.
65. Y. Feng, D. He, Z. Yao, and D. J. Klionsky, "The machinery of macroautophagy," Cell Research, vol. 24, no. 1, pp. 24-41, 2014.
66. J. Kim, M. Kundu, B. Viollet, and K.-L. Guan, "AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1," Nature Cell Biology, vol. 13, no. 2, pp. 132-141, 2011.
67. N. Mizushima, A. Yamamoto, M. Matsui, T. Yoshimori, and Y. Ohsumi, "In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fuorescent autophagosome marker," Molecular Biology of the Cell, vol. 15, no. 3, pp. 1101-1111, 2004.
68. C. He and D.J. Klionsky, "Regulation mechanisms and signaling pathways of autophagy," Annual Review of Genetics, vol. 43, pp. 67-93, 2009.
69. L. Yang, P. Li, S. Fu, E. S. Calay, and G. S. Hotamisligil, "Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance," Cell Metabolism, vol. 11, no. 6, pp. 467-478, 2010.
70. R. Singh, S. Kaushik, Y. Wang et al., "Autophagy regulates lipid metabolism," Nature, vol. 458, no. 7242, pp. 1131-1135, 2009.
71. J. Lee and U. Ozcan, "Unfolded protein response signaling and metabolic diseases," The Journal of Biological Chemistry, vol. 289, no. 3, pp. 1203-1211, 2014.
72. S. Bernales, K.L. McDonald, and P. Walter, "Autophagycounter-balances endoplasmic reticulum expansion during the unfolded protein response," PLoS Biology, vol. 4, no. 12, article e423, 2006.
73. T. Yorimitsu, U. Nair, Z. Yang, and D. J. Klionsky, "Endoplasmic reticulum stress triggers autophagy," Journal of Biological Chemistry, vol. 281, no. 40, pp. 30299-30304, 2006.
74. C. Ebato, T. Uchida, M. Arakawa et al., "Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet," Cell Metabolism, vol. 8, no. 4, pp. 325-332, 2008.
75. H. S. Jung, K. W. Chung, J. W. Kim et al., "Loss of autophagy diminishes pancreatic β cell mass and function with resultant hyperglycemia," Cell Metabolism, vol. 8, no. 4, pp. 318-324, 2008.
76. P. Westermark, C. Wernstedt, E. Wilander, and K. Sletten, "A novel peptide in the calcitonin gene related peptide family as an amyloid fbril protein in the endocrine pancreas," Biochemical and Biophysical Research Communications, vol. 140, no. 3, pp. 827-831, 1986.
77. J. Kim, H. Cheon, Y. T. Jeong et al., "Amyloidogenic peptide oligomer accumulation in autophagy-defcient β cells induces diabetes," Journal of Clinical Investigation, vol. 124, no. 8, pp. 3311-3324, 2014.
78. J. F. Rivera, S. Costes, T. Gurlo, C. G. Glabe, and P. C. Butler, "Autophagy defends pancreatic β cells from human islet amyloid polypeptide-induced toxicity," Journal of Clinical Investigation, vol. 124, no. 8, pp. 3489-3500, 2014.
79. N. Shigihara, A. Fukunaka, A. Hara et al., "Human IAPP-induced pancreatic β cell toxicity and its regulation by autophagy," Journal of Clinical Investigation, vol. 124, no. 8, pp. 3634-3644, 2014.
80. M. Masini, M. Bugliani, R. Lupi et al., "Autophagy in human type 2 diabetes pancreatic beta cells," Diabetologia, vol. 52, no. 6, pp. 1083-1086, 2009.
81. G. Ashraf and T. L. Schwarz, "The pathways of mitophagy for quality control and clearance of mitochondria," Cell Death & Diferentiation, vol. 20, no. 1, pp. 31-42, 2013.
82. Y. Zhang, S. Goldman, R. Baerga, Y. Zhao, M. Komatsu, and S. Jin, "Adipose-specifc deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 19860-19865, 2009.
83. R. Singh, Y. Xiang, Y. Wang et al., "Autophagy regulates adipose mass and diferentiation in mice," Journal of Clinical Investigation, vol. 119, no. 11, pp. 3329-3339, 2009.
84. Y. M. Lim, H. Lim, K. Y. Hur et al., "Systemic autophagy insufciency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes," Nature Communications, vol. 5, article 4934, 2014.
85. K. H. Kim, Y. T. Jeong, H. Oh et al., "Autophagy defciency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine," Nature Medicine, vol. 19, no. 1, pp. 83-92, 2013.
86. M. Kars, L. Yang, M. F. Gregor et al., "Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women," Diabetes, vol. 59, no. 8, pp. 1899-1905, 2010.
87. C. Xiao, A. Giacca, and G. F. Lewis, "Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction in humans," Diabetes, vol. 60, no. 3, pp. 918-924, 2011.
88. J. M. Axten, J. R. Medina, Y. Feng et al., "Discovery of 7-methyl-5-(1-[3-(trifuoromethyl)phenyl]acetyl-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective frst-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)," Journal of Medicinal Chemistry, vol. 55, no. 16, pp. 7193-7207, 2012.
89. S. Fu, A. Yalcin, G. Y. Lee et al., "Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity," Science Translational Medicine, vol. 7, no. 292, Article ID 292ra98, 2015.
90. C. S. McAlpine, A. J. Bowes, M. I. Khan, Y. Shi, and G. H. Werstuck, "Endoplasmic reticulum stress and glycogen synthase kinase-3β activation in apolipoprotein E-defcient mouse models of accelerated atherosclerosis," Arteriosclerosis, Trombosis, and Vascular Biology, vol. 32, no. 1, pp. 82-91, 2012.
91. M. Boyce, K. F. Bryant, C. Jousse et al., "A selective inhibitor of elF2α dephosphorylation protects cells from ER stress," Science, vol. 307, no. 5711, pp. 935-939, 2005.
92. P. Tsaytler, H. P. Harding, D. Ron, and A. Bertolotti, "Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis," Science, vol. 332, no. 6025, pp. 91-94, 2011.
93. K. Volkmann, J. L. Lucas, D. Vuga et al., "Potent and selective inhibitors of the inositol-requiring enzyme 1 endoribonuclease," The Journal of Biological Chemistry, vol. 286, no. 14, pp. 12743-12755, 2011.
94. I. Papandreou, N. C. Denko, M. Olson et al., "Identifcation of an Ire1alpha endonuclease specifc inhibitor with cytotoxic activity against human multiple myeloma," Blood, vol. 117, no. 4, pp. 1311-1314, 2011.
95. N. Mimura, M. Fulciniti, G. Gorgun et al., "Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma," Blood, vol. 119, no. 24, pp. 5772-5781, 2012.
96. B. C. S. Cross, P. J. Bond, P. G. Sadowski et al., "The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 15, pp. E869-E878, 2012.
97. R. Ghosh, L. Wang, E. S. Wang et al., "Allosteric inhibition of the IRE1α RNase preserves cell viability and function during endoplasmic reticulum stress," Cell, vol. 158, no. 3, pp. 534-548, 2014.
98. R. Ringseis, J. Keller, and K. Eder, "Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine defciency," European Journal of Nutrition, vol. 51, no. 1, pp. 1-18, 2012.
99. J. C. Bae, W. Y. Lee, K. H. Yoon et al., "Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial," Diabetes Care, vol. 38, no. 7, pp. 1245-1252, 2015.
100. 10 supplementation on metabolic profle in diabetes: a systematic review and meta-analysis," Journal of Clinical Pharmacy and Terapeutics, vol. 40, no. 4, pp. 413-418, 2015.
101. J. C. Ratlif, L. B. Palmese, E. L. Reutenauer, and C. Tek, "An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes," Clinical Schizophrenia and Related Psychoses, vol. 8, no. 4, pp. 196-200, 2015.
102. S. Porasuphatana, S. Suddee, A. Nartnampong, J. Konsil, B. H. B.Pharm, and A. Santaweesuk, "Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alphalipoic acid: a randomized double-blinded placebocontrolled study," Asia Pacifc Journal of Clinical Nutrition, vol. 21, no. 1, pp. 12-21, 2012.
103. A. E. Huerta, S. Navas-Carretero, P. L. Prieto-Hontoria, J. A. Martínez, and M. J. Moreno-Aliaga, "Efects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss," Obesity, vol. 23, no. 2, pp. 313-321, 2015.
104. E. H. Koh, W. J. Lee, S. A. Lee et al., "Efects of alpha-lipoic acid on body weight in obese subjects," The American Journal of Medicine, vol. 124, no. 1, pp. 85.e1-85.e8, 2011.
105. Y. Zhang, P. Han, N. Wu et al., "Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-infammatory efects," Obesity, vol. 19, no. 8, pp. 1647-1653, 2011.
106. P. L. Prieto-Hontoria, P. Pérez-Matute, M. Fernández-Galilea, J. Alfredo Martinez, and M. J. Moreno-Aliaga, "Efects of lipoic acid on AMPK and adiponectin in adipose tissue of low-and high-fat-fed rats," European Journal of Nutrition, vol. 52, no. 2, pp. 779-787, 2013.
107. W. L. Chen, C. H. Kang, S. G. Wang, and H. M. Lee, "alpha-Lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of AMP-activated protein kinase," Diabetologia, vol. 55, no. 6, pp. 1824-1835, 2012.
108. Y. Wang, X. Li, Y. Guo, L. Chan, and X. Guan, "Alpha-lipoic acid increases energy expenditure by enhancing adenosine mono-phosphate-activated protein kinase-peroxisome proliferator-activated receptor-gamma coactivator-1alpha signaling in the skeletal muscle of aged mice," Metabolism, vol. 59, no. 7, pp. 967-976, 2010.
109. M.-S. Kim, J.-Y. Park, C. Namkoong et al., "Anti-obesity efects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase," Nature Medicine, vol. 10, no. 7, pp. 727-733, 2004.
110. M. C. Castro, F. Francini, J. J. Gagliardino, and M. L. Massa, "Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress," Biochimica et Biophysica Acta, vol. 1840, no. 3, pp. 1145-1151, 2014.
111. S. K. Jain, R. McVie, J. J. Jaramillo, M. Palmer, and T. Smith, "Efect of modest vitamin E supplementation on blood glycated hemoglobin and triglyceride levels and red cell indices in type I diabetic patients," Journal of the American College of Nutrition, vol. 15, no. 5, pp. 458-461, 1996.
112. A. Ceriello, D. Giugliano, A. Quatraro, C. Donzella, G. Dipalo, and P. J. Lefebvre, "Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications?" Diabetes Care, vol. 14, no. 1, pp. 68-72, 1991.
113. S. Shab-Bidar, Z. Mazloum, and Z. Mousavi-Shirazifard, "Daily vitamin E supplementation does not improve metabolic and glycemic control in type 2 diabetic patients: a double blinded randomized controlled trial," Journal of Diabetes, vol. 5, no. 1, pp. 57-58, 2013.
114. P. A. Economides, L. Khaodhiar, A. Caselli et al., "The efect of vitamin E on endothelial function of micro-and macrocirculation and lef ventricular function in type 1 and type 2 diabetic patients," Diabetes, vol. 54, no. 1, pp. 204-211, 2005.
115. F. J. Gómez-Pérez, V. E. Valles-Sánchez, J. C. López-Alvarenga et al., "Vitamin E modifes neither fructosamine nor HbA1c levels in poorly controlled diabetes," Revista de Investigación Clínica, vol. 48, no. 6, pp. 421-424, 1996.
116. Y.-C. Chang, Y.-H. Yu, J.-Y. Shew et al., "Defciency of NPGPx, an oxidative stress sensor, leads to obesity in mice and human," The EMBO Molecular Medicine, vol. 5, no. 8, pp. 1165-1179, 2013.
117. J.-R. Kim, H.-H. Ryu, H. J. Chung et al., "Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation," Experimental and Molecular Medicine, vol. 38, no. 2, pp. 162-172, 2006.
118. E. L. B. Novelli, P. P. Santos, H. B. Assalin et al., "N-acetylcysteine in high-sucrose diet-induced obesity: energy expenditure and metabolic shifing for cardiac health," Pharmacological Research, vol. 59, no. 1, pp. 74-79, 2009.
119. -/- mice," Free Radical Biology and Medicine, vol. 52, no. 5, pp. 841-849, 2012.
120. K. Liu, R. Zhou, B. Wang, and M.-T. Mi, "Efect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials," American Journal of Clinical Nutrition, vol. 99, no. 6, pp. 1510-1519, 2014.
121. D.-K. Kim, D. Ryu, M. Koh et al., "Orphan nuclear receptor estrogen-related receptor ? (ERR?) is key regulator of hepatic gluconeogenesis," Journal of Biological Chemistry, vol. 287, no. 26, pp. 21628-21639, 2012.
122. A. J. Sanyal, N. Chalasani, K. V. Kowdley et al., "Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis," The New England Journal of Medicine, vol. 362, no. 18, pp. 1675-1685, 2010.
123. W. Li, W. Wu, H. Song et al., "Targeting Nrf2 by dihydro-CDDO-trifuoroethyl amide enhances autophagic clearance and viability of β-cells in a setting of oxidative stress," FEBS Letters, vol. 588, no. 12, pp. 2115-2124, 2014.
124. R. Baerga, Y. Zhang, P.-H. Chen, S. Goldman, and S. Jin, "Targeted deletion of autophagy-related 5 (atg5) impairs adipo-genesis in a cellular model and in mice," Autophagy, vol. 5, no. 8, pp. 1118-1130, 2009.
125. J.-O. Pyo, S.-M. Yoo, H.-H. Ahn et al., "Overexpression of Atg5 in mice activates autophagy and extends lifespan," Nature Communications, vol. 4, article 2300, 2013.
126. S. Kaushik, J. A. Rodriguez-Navarro, E. Arias et al., "Autophagy in hypothalamic agrp neurons regulates food intake and energy balance," Cell Metabolism, vol. 14, no. 2, pp. 173-183, 2011.
127. S. Kaushik, E. Arias, H. Kwon et al., "Loss of autophagy in hypothalamic POMC neurons impairs lipolysis," EMBO Reports, vol. 13, no. 3, pp. 258-265, 2012.
128. B. Coupé, Y. Ishii, M. O. Dietrich, M. Komatsu, T. L. Horvath, and S. G. Bouret, "Loss of autophagy in pro-opiomelanocortin neurons perturbs axon growth and causes metabolic dysregula-tion," Cell Metabolism, vol. 15, no. 2, pp. 247-255, 2012.
129. N. Martinez-Lopez, D. Athonvarangkul, S. Sahu et al., "Autophagy in Myf5+ progenitors regulates energy and glucose homeostasis through control of brown fat and skeletal muscle development," EMBO Reports, vol. 14, no. 9, pp. 795-803, 2013.
130. R. Malhotra, J. P. Warne, E. Salas, A. W. Xu, and J. Debnath, "Loss of Atg12, but not Atg5, in pro-opiomelanocortin neurons exacerbates diet-induced obesity," Autophagy, vol. 11, no. 1, pp. 145-154, 2015.
131. S. G. Fonseca, S. Ishigaki, C. M. Oslowski et al., "Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells," The Journal of Clinical Investigation, vol. 120, no. 3, pp. 744-755, 2010.